Back
Coherus BioSciences Vs. Nektar Therapeutics Industry Stock Comparison
Buy
51
CHRS
Coherus BioSciences
Last Price:
2.12
Seasonality Move:
13.84%
Buy
59
NKTR
Nektar Therapeutics
Last Price:
1.66
Seasonality Move:
-3.53%
Buy
51
Coherus BioSciences (CHRS)
is a Buy
Is Coherus BioSciences a Buy, Sell or Hold?
- The current Coherus BioSciences [CHRS] share price is $2.23. The Score for CHRS is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
- CHRS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
59
Nektar Therapeutics (NKTR)
is a Buy
Is Nektar Therapeutics a Buy, Sell or Hold?
- The current Nektar Therapeutics [NKTR] share price is $1.64. The Score for NKTR is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
- NKTR is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CHRS Stock Price Chart
What is Coherus BioSciences's stock price today?
-
The Coherus BioSciences share price today is $2.23
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CHRS is experiencing slight buying pressure.
NKTR Stock Price Chart
What is Nektar Therapeutics's stock price today?
-
The Nektar Therapeutics share price today is $1.64
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NKTR is experiencing slight buying pressure.
CHRS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.03 | Sell |
| Relative Strength Index (14 RSI): | 51.63 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.04 - 2.36) | Buy |
| Bollinger Bands (100): | (2.09 - 2.67) | Sell |
NKTR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.13 | Buy |
| Relative Strength Index (14 RSI): | 61.65 | Buy |
| Chaikin Money Flow: | 347645 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.31 - 1.59) | Buy |
| Bollinger Bands (100): | (0.5 - 1.24) | Buy |
CHRS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.15 | Buy |
| 20-day SMA: | 2.14 | Buy |
| 50-day SMA: | 2.26 | Sell |
| 200-day SMA: | 3.03 | Sell |
| 8-day EMA: | 2.18 | Buy |
| 20-day EMA: | 2.18 | Buy |
| 50-day EMA: | 2.26 | Sell |
| 200-day EMA: | 3.2 | Sell |
NKTR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.58 | Buy |
| 20-day SMA: | 1.48 | Buy |
| 50-day SMA: | 1.16 | Buy |
| 200-day SMA: | 0.73 | Buy |
| 8-day EMA: | 1.56 | Buy |
| 20-day EMA: | 1.45 | Buy |
| 50-day EMA: | 1.22 | Buy |
| 200-day EMA: | 1.02 | Buy |
Coherus BioSciences Earnings Growth & CHRS Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.10 per share, an increase next quarter of $0.06 per share, an increase this year of $0.82 per share, and an increase next year of $0.68 per share.
Nektar Therapeutics Earnings Growth & NKTR Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.59 per share, and an increase next year of $0.06 per share.
Coherus BioSciences Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Nektar Therapeutics Technical Analysis
| Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | May 7 | May 8 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | 07 | 08 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||